Why is NeuroPace, Inc. ?
1
Positive results in Mar 26
- OPERATING CASH FLOW(Y) Highest at USD -9.42 MM
- NET PROFIT(HY) Higher at USD -9.25 MM
- ROCE(HY) Highest at -111.38%
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 47.45%, its profits have risen by 23.6%
3
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Consistent Returns over the last 3 years
- Along with generating 47.45% returns in the last 1 year, the stock has outperformed S&P 500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to NeuroPace, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is NeuroPace, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
NeuroPace, Inc.
47.45%
2.34
61.07%
S&P 500
25.41%
1.92
13.25%
Quality key factors
Factor
Value
Sales Growth (5y)
19.44%
EBIT Growth (5y)
-5.64%
EBIT to Interest (avg)
-3.11
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
1.04
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
23.58
EV to EBIT
-27.46
EV to EBITDA
-31.18
EV to Capital Employed
23.65
EV to Sales
4.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-86.11%
ROE (Latest)
-110.24%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Technical Movement
8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -9.42 MM
NET PROFIT(HY)
Higher at USD -9.25 MM
ROCE(HY)
Highest at -111.38%
RAW MATERIAL COST(Y)
Fallen by -6.3% (YoY
-5What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.43 times
NET SALES(Q)
Lowest at USD 22.07 MM
PRE-TAX PROFIT(Q)
At USD -6.52 MM has Fallen at -24.39%
NET PROFIT(Q)
At USD -6.52 MM has Fallen at -24.39%
Here's what is working for NeuroPace, Inc.
Operating Cash Flow
Highest at USD -9.42 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Raw Material Cost
Fallen by -6.3% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for NeuroPace, Inc.
Net Sales
Lowest at USD 22.07 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Net Sales
At USD 22.07 MM has Fallen at -11.72%
over average net sales of the previous four periods of USD 25 MMMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -6.52 MM has Fallen at -24.39%
over average net sales of the previous four periods of USD -5.24 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -6.52 MM has Fallen at -24.39%
over average net sales of the previous four periods of USD -5.24 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Inventory Turnover Ratio
Lowest at 1.43 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio






